Study guide

7.6 TOLAC, VBAC & Uterine Rupture

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

7.6 TOLAC, VBAC & Uterine Rupture

Key Takeaways Explain This Topic AI

Uterine rupture risk is 0.5 to 0.9 percent with one prior low transverse cesarean and 4 to 9 percent or higher with a prior classical or T-shaped incision, which is an absolute contraindication to trial of labor.

An acute abnormal fetal heart rate pattern is the earliest and most sensitive sign of uterine rupture, present in more than 70 percent of cases.

Sudden loss of fetal station, with a previously engaged head retracting to a high floating position, is a hallmark of uterine rupture.

Prostaglandins are absolutely prohibited for cervical ripening in a scarred uterus, and the transcervical Foley catheter is the ripening method of choice.

Epidural analgesia is safe and encouraged in trial of labor after cesarean because it does not mask rupture, which presents first with fetal heart rate change and with pain that breaks through the block.

Last updated: September 2026

Trial of Labor After Cesarean (TOLAC) & VBAC Management

Trial of labor after cesarean (TOLAC) refers to a planned attempt to labor by a woman who has previously given birth via cesarean delivery, with the goal of achieving a vaginal birth after cesarean (VBAC).

Candidate Eligibility Criteria (ACOG Guidelines)

One or Two Prior Low Transverse Cesarean Deliveries: Documented transverse incision in the lower uterine segment.

Clinically Adequate Maternal Pelvis: Clinically evaluated as adequate for the estimated fetal size.

No Prior Uterine Scars: No history of classical, vertical, T-shaped, or inverted-T hysterotomy incisions, and no history of prior uterine rupture or extensive transmural myomectomy entering the uterine cavity.

Immediate Surgical Capability: Labor must take place in a facility equipped for emergency cesarean delivery with immediate availability of anesthesia, surgical personnel, and neonatal resuscitation throughout active labor.

Predictors of VBAC Success

Overall, 60% to 80% of women who undergo TOLAC achieve successful vaginal delivery .

Strongest Positive Predictor: A prior successful vaginal delivery (especially a prior successful VBAC). Women with a prior vaginal birth have an > 85% to 90% VBAC success rate and a significantly lower incidence of uterine rupture.

Other Favorable Factors: Spontaneous labor onset, prior cesarean performed for a non-recurring indication (e.g., breech presentation, herpes lesion, fetal heart rate abnormality), maternal age < 35, normal BMI, and spontaneous cervical dilation upon admission.

Unfavorable Predictors: Recurring indication for prior cesarean (arrest of dilation or arrest of descent), labor induction or augmentation, maternal obesity (BMI ≥ 30), advanced maternal age, gestational age > 40 weeks, fetal macrosomia (> 4,000 g), and short inter-pregnancy interval (< 18 months from prior cesarean to next conception).

Uterine Rupture Risks by Incision Type

  • Previous Uterine Incision Type Risk of Uterine Rupture during Labor TOLAC Eligibility
  • One Prior Low Transverse Cesarean (LTCS) 0.5% to 0.9% (~1 in 100 to 200) Eligible Candidate
  • Two Prior Low Transverse Cesareans 0.9% to 1.8% Eligible Candidate
  • Prior Low Vertical Incision 1.0% to 2.0% Candidate only if scar did not extend into fundus
  • Prior Classical (High Vertical) Incision 4.0% to 9.0%+ STRICTLY CONTRAINDICATED (Repeat Cesarean at 36–37w)
  • Prior T-Shaped or Inverted-T Incision 4.0% to 9.0%+ STRICTLY CONTRAINDICATED
  • Prior Documented Uterine Rupture 5.0% to 32.0% STRICTLY CONTRAINDICATED
  • Uterine Rupture: Pathophysiology, Clinical Presentation & Intrapartum Care

Uterine rupture is an acute tearing separation of all myometrial layers, including the overlying visceral peritoneum (complete rupture), often resulting in extrusion of the fetus, placenta, or umbilical cord into the maternal peritoneal cavity.

Clinical Presentation & Hallmark Signs

Acute Abnormal Fetal Heart Rate Pattern: The earliest, most consistent, and most sensitive sign of uterine rupture, present in > 70% of cases . Typically manifests as sudden, profound, persistent bradycardia, recurrent late decelerations, or deep prolonged decelerations.

Acute, Constant, Severe Abdominal Pain: Sharp, tearing lower abdominal pain that persists between contractions and often "breaks through" an otherwise fully functioning epidural analgesia block .

Sudden Loss of Fetal Station: The fetal presenting part that was previously engaged (+1 or +2 station) retracts upward and floats away (–2 or –3 station) on digital examination as the fetus is extruded through the hysterotomy tear into the abdominal cavity.

Cessation of Uterine Contractions: Contractions abruptly stop, or the baseline intrauterine resting tone suddenly drops on the intrauterine pressure catheter (IUPC).

Maternal Hemodynamic Collapse: Tachycardia, hypotension, cool clammy extremities, syncope, and maternal hypovolemic shock secondary to massive intra-abdominal hemorrhage.

Vaginal Bleeding & Hematuria: Frank vaginal bleeding may be present (though bleeding is predominantly internal/intra-abdominal); gross hematuria may occur if the rupture extends into the bladder base.

Intrapartum TOLAC Management Guidelines

Continuous Electronic Fetal Monitoring (EFM): Continuous cardiotocography is mandatory from the onset of labor. Intermittent auscultation is unsafe in TOLAC.

Vascular Access & Blood Banking: Establish functioning large-bore intravenous access (16- or 18-gauge) on admission; draw type and antibody screen; confirm blood bank availability.

Cervical Ripening in TOLAC:

Mechanical Ripening is Safe: Transcervical Foley bulb catheter (30 to 60 mL) is the ripening modality of choice. It achieves cervical change mechanically without increasing the risk of uterine rupture.

PROSTAGLANDINS ARE ABSOLUTELY CONTRAINDICATED: Both misoprostol (PGE1) and dinoprostone (PGE2) are strictly prohibited for cervical ripening in TOLAC due to a 5- to 10-fold increase in uterine rupture rates .

Oxytocin Usage: Oxytocin may be used for induction or augmentation of labor in TOLAC candidates with careful titration, but requires extreme vigilance. Avoid excessive doses and prevent uterine tachysystole, as high doses are associated with an increased rupture risk (up to 1% to 2%).

Epidural Analgesia: Epidural analgesia is safe, appropriate, and encouraged in TOLAC. It does not mask the signs of uterine rupture (abnormal FHR patterns occur first, and severe peritoneal pain typically breaks through regional neuraxial blockade).